National Aggregate

Five-Year Summary: January 2007 to December 2011

Tables and graphs report on cancer screening services provided through the program in a recent 5-year period. The data represent clinical services funded directly through the NBCCEDP as reported in the October 2012 submission of the NBCCEDP Minimum Data Elements (MDE).

National aggregate data are typically used to report results from the program and as a standard to compare results of grantee programs. Comparing data across grantee programs is not advised due to extensive variation across programs. For information on interpreting the data, refer to Screening Program Data. For information on the program, refer to About the Program.

Screening Totals by Year

Number of Women Screened by Year

Program Overview

Women Served through the NBCCEDP

Category	Number
Women served [1]	1,814,449
Women screened [2]	1,740,767
Women receiving Pap tests	1,152,080
Women receiving mammography	1,042,901

Each category reports counts of unduplicated women receiving services within the 5-year period. Women may be counted in more than one category.

1: Women served includes women receiving any NBCCEDP-funded screen or diagnostic procedure.

2: Women screened includes women receiving any NBCCEDP-funded screen (mammography, clinical breast exam, or Pap test).

Data source: October 2012 submission of NBCCEDP Minimum Data Elements (MDE).

Cervical Cancer Screening

Distribution of Women Receiving Pap Tests by Race/Ethnicity

This pie chart illustrates the distribution of 1,152,080 women receiving an NBCCEDP-funded Pap test from January 2007 to December 2011 by race and ethnicity.

Distribution of Women Receiving Pap Tests by Age

This pie chart illustrates the distribution of 1,152,080 women receiving an NBCCEDP-funded Pap test from January 2007 to December 2011 by age.

Cervical Results and Outcomes

Category	Number
Pap tests provided	1,552,403
Pap tests with abnormal results [1]	48,446
Percentage of Pap tests with abnormal results	3.1
Age-adjusted percentage [2]	2.9
Cervical cancers or premalignant cervical lesions [3]	28,141
CIN1 or LSIL	17,042
CIN2 or worse [4]	11,099
Rate of CIN2 or worse detected per 1,000 Pap tests [4]	7.1
Age-adjusted rate per 1,000 Pap tests [2]	6.5

1: Abnormals include Pap test results of: low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical squamous cells of undetermined significance - cannot exclude HSIL (ASC-H), atypical glandular cells (AGC), and squamous cell cancer.

2: Adjusted to the age distribution of NBCCEDP participants having Pap tests performed in calendar year 2000.

3: Includes LSIL, HSIL, cervical intraepithelial neoplasia (CIN)1, CIN2, CIN3, carcinoma in situ (CIS), and invasive cervical cancer.

4: Includes HSIL, CIN2, CIN3, CIS, and invasive cervical cancer.

Table includes only NBCCEDP-funded Pap tests. An additional 31,188 women, not included above, were diagnosed with LSIL, HSIL, CIN1, CIN2, CIN3, CIS, or invasive cervical cancer through the NBCCEDP following a Pap test funded through another source.

Breast Cancer Screening

Distribution of Women Receiving Mammograms by Race/Ethnicity

This pie chart illustrates the distribution of 1,042,901 women receiving an NBCCEDP-funded mammogram from January 2007 to December 2011 by race and ethnicity.

Distribution of Women Receiving Mammograms by Age

This pie chart illustrates the distribution of 1,042,901 women receiving an NBCCEDP-funded mammogram from January 2007 to December 2011 by age.

Breast Results and Outcomes

Category	Number
Mammograms provided	1,617,110
Mammograms with abnormal results [1]	231,282
Percentage of mammograms with abnormal results	14.3
Age-adjusted percentage [2]	15.0
Breast cancers detected [3]	16,922
Rate of breast cancers detected per 1,000 mammograms	10.5
Age-adjusted rate per 1,000 mammograms [2]	10.9

1: Abnormals include mammogram results of: suspicious abnormality, highly suggestive of malignancy, and assessment incomplete (further imaging studies or film comparisons required).

2: Adjusted to the age distribution of NBCCEDP participants 40 years of age and older having mammograms performed in calendar year 2000.

3: Breast cancers include invasive breast cancer, ductal carcinoma in situ (DCIS), and other in situ excluding lobular carcinoma in situ (LCIS).

Table includes only NBCCEDP-funded mammograms provided to women age 40 and older. An additional 5,918 women, not included above, were diagnosed with CIS (other), DCIS, or invasive breast cancer through the NBCCEDP following a mammogram funded through another source.